Healius

HLS.ASX

Health Care

Pathology company.

Market Data

Price

$0.355

-0.0%

Market Cap

$261.4M

P/E Ratio

-100000.0x

EPS

$-0.756

Div. Yield

0.00%

52-Week Change

-0.5%

Recent Announcements

10 Jul 2026 Sph Neutral

Ceasing to be a substantial holder

JPMorgan Chase & Co. and its affiliates ceased to be a substantial holder.

7 Jul 2026 Sph Neutral

Becoming a substantial holder

JPMorgan Chase & Co. and its affiliates became a substantial holder (5.01%).

7 Jul 2026 Sph Neutral

Ceasing to be a substantial holder

Vanguard Group (The Vanguard Group, Inc. ceased to be a substantial holder.

3 Jul 2026 Sph Neutral

Becoming a substantial holder

Citigroup Global Markets Australia Pty Limited (ACN 003 114 832) became a substantial holder (5.2366%).

29 May 2026 Sph Neutral

Ceasing to be a substantial holder from MQG

MQG ceased to be a substantial holder.

27 May 2026 Date Announcement Neutral

Earnings Release - 19 August 2026

Upcoming earnings release expected 19 August 2026 (from Yahoo Finance (confirmed))

26 May 2026 Sph Neutral

Becoming a substantial holder from MQG

MQG became a substantial holder (5.06%).

22 May 2026 Sph Neutral

Ceasing to be a substantial holder from MQG

MQG ceased to be a substantial holder.

21 May 2026 Sph Neutral

Becoming a substantial holder from MQG

MQG became a substantial holder (5.06%).

20 May 2026 Sph Neutral

Ceasing to be a substantial holder from MQG

MQG ceased to be a substantial holder.

Get real-time alerts for HLS

Receive AI-powered earnings summaries and instant notifications when Healius releases results.